We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PK icon
1101
Park Hotels & Resorts
PK
$3.03B
$465K ﹤0.01%
16,886
-318,154
-95% -$9.54M
HWM icon
1102
Howmet Aerospace
HWM
$115B
$462K ﹤0.01%
+23,338
New +$394K
MWA icon
1103
Mueller Water Products
MWA
$3.94B
$454K ﹤0.01%
+46,234
New +$462K
TME icon
1104
Tencent Music
TME
$15.3B
$452K ﹤0.01%
+30,180
New +$477K
PZN
1105
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$452K ﹤0.01%
52,634
+10,187
+24% +$92.2K
BWA icon
1106
BorgWarner
BWA
$13.1B
$450K ﹤0.01%
+12,180
New +$432K
KMDA icon
1107
Kamada
KMDA
$403M
$450K ﹤0.01%
82,023
+33,703
+70% +$193K
SPTN
1108
DELISTED
SpartanNash
SPTN
$449K ﹤0.01%
+38,443
New +$548K
CPL
1109
DELISTED
CPFL Energia S.A.
CPL
$446K ﹤0.01%
+28,531
New +$427K
MYE icon
1110
Myers Industries
MYE
$1.23B
$435K ﹤0.01%
22,597
+22,306
+7,665% +$402K
XOMA
1111
DELISTED
Xoma
XOMA
$434K ﹤0.01%
+29,185
New +$438K
DHC
1112
Diversified Healthcare Trust
DHC
$2.28B
$430K ﹤0.01%
51,942
+42,652
+459% +$355K
ASUR icon
1113
Asure Software
ASUR
$222M
$429K ﹤0.01%
52,134
-287,008
-85% -$1.98M
MPWR icon
1114
Monolithic Power Systems
MPWR
$65.8B
$429K ﹤0.01%
+3,160
New +$430K
TESS
1115
DELISTED
Tessco Technologies Inc
TESS
$428K ﹤0.01%
+23,940
New +$438K
SBBX
1116
DELISTED
SB One Bancorp Common Stock
SBBX
$428K ﹤0.01%
19,169
+17,329
+942% +$391K
IPGP icon
1117
IPG Photonics
IPGP
$3.81B
$427K ﹤0.01%
2,765
TXN icon
1118
Texas Instruments
TXN
$255B
$424K ﹤0.01%
+3,693
New +$413K
VSH icon
1119
Vishay Intertechnology
VSH
$5.7B
$423K ﹤0.01%
+25,581
New +$451K
OMAB icon
1120
Grupo Aeroportuario Centro Norte
OMAB
$5.06B
$422K ﹤0.01%
8,642
-62,986
-88% -$3.11M
EXC icon
1121
Exelon
EXC
$48.2B
$412K ﹤0.01%
+12,057
New +$426K
NRP icon
1122
Natural Resource Partners
NRP
$1.3B
$412K ﹤0.01%
11,612
-7,489
-39% -$299K
AINC
1123
DELISTED
Ashford Inc.
AINC
$410K ﹤0.01%
12,892
+8,236
+177% +$394K
KZR
1124
DELISTED
Kezar Life Sciences
KZR
$409K ﹤0.01%
5,302
+1,336
+34% +$208K
WWD icon
1125
Woodward
WWD
$25B
$408K ﹤0.01%
+3,609
New +$387K

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.